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Educational aims
•	 To increase awareness of the role played by sex and gender in disease pathogenesis and 
progression
•	 To disseminate evidence for sex and gender specific influences on a select number of 
endocrine conditions
•	 To highlight those diseases where we have local data to support sex and gender 
specific medicine in endocrinology.  
Josanne Vassallo MD PhD FRCP
Abstract
There is increasing evidence for a distinct role(s) for sex 
and gender in disease onset, progression and response to 
treatment. This article will review the evidence for sex and 
gender specific differences in the field of endocrinology and 
metabolism, citing examples of such influences in a variety of 
endocrine disorders both internationally and locally. 
Introduction
Gender can be defined as the spectrum 
of physical, biological, mental and 
behavioral characteristics particular to, and 
differentiating between, masculinity and 
femininity. Gender is generally influenced 
by cultural, psychosocial and educational 
factors. In contrast sex generally refers to the 
biological differences arising due to genetic 
and hormonal influences on males and 
females. In reality, the two terms are often 
used interchangeably. 
Gene-environment interactions
 It has become increasingly clear that 
disease and disease processes occur as a 
result of the interplay between genes and 
the environment, lending credence to the 
hypothesis that sex chromosomal linkage of 
specific genes together with environmental 
interactions forms the basis for the 
predominance of certain diseases in one sex 
as opposed to the other. It is interesting to 
note that the X chromosome carries almost 
2000 genes responsible for encoding protein 
whilst the Y chromosome carries a distinct 
set of 78 genes. Researchers continue to 
report significant sex and gender differences 
in the incidence and prevalence of disease, 
in perception of disease as well as in disease 
progression and response to treatment. This 
paper will attempt to highlight a few of the 
gender specific differences which have been 
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Figure 1: Gender distribution of the major autoimmune diseases. The numbers above the 
bars refer to the total number of disease cases (×1,000,000) in the USA. 4
Figure 2: A model for the multifactorial nature of autoimmune disease.5
documented in the field of Endocrinology 
and Diabetes with reference to studies of 
relevance to the Maltese population when 
available.
Pituitary gland
The pituitary gland has long been dubbed 
the master gland in the endocrine system. 
Benign pituitary adenomas can arise in the 
gland and have significant effects on the 
regulation of a number of other endocrine 
glands in the human body. An analysis of 
the incidence and prevalence of pituitary 
adenomas in Malta revealed that there is 
a lower prevalence of macroadenomas in 
females as compared males (29.5 vs 75%) 
with a significant increase in standardized 
incidence rates in females of child bearing 
age as compared to males. Females, on 
the other hand, have a higher prevalence 
of microadenomas (73.3/100,000 vs 
11.6/100,000) with an SIR of 5.3/100,000 
in women vs 0.63/100,000 in men.1 The 
reason for this difference is unknown.
Thyroid gland
Gender specific differences have also been 
reported in a number of malignant endocrine 
tumours.  In 2008, the highest incidence 
rate of thyroid cancer was estimated to be in 
France, where the female rate was five times 
higher than the rate of the lowest ranking 
country, Greece (18.6 versus 3.3 per 100,000 
females). Age-standardised rates for Malta 
revealed a rate of  9.3 per 100,000 females 
vs 0.9 per 100,000 males as compared to 
Greece where the SIR was 3.3 per 100,000 in 
females vs 1.1 per 100,000 in males. 2 Males 
developing thyroid cancer, on the other 
hand, tend to present later than females and 
have a worse prognosis.3
Autoimmune disease
Similarly autoimmune diseases occur 
predominantly in women (Figure 1).4 For 
example, 95% and 88% of Hashimoto’s 
thyroiditis and Graves’ disease respectively 
occur in females. To date we do not 
have any data regarding the incidence or 
prevalence of autoimmune disease in Malta 
and specifically none with respect to sex and 
gender differences.  
A number of possible initiating factors 
and mechanisms have been postulated 
(Figure 2). There is a growing body of 
evidence that the observed sex and gender 
related differences are multifactorial in 
origin. Sex hormones, which determine 
biological differences, represent important 
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modulatory factors in the immune and 
autoimmune response.5
Parathyroid glands
Primary hyperparathyroidism represents 
another endocrinological condition that 
predominates in women The prevalence 
of primary hyperparathyroidism has been 
estimated to be 3 per 1000 in the general 
population and as high as 21 per 1000 in 
postmenopausal women. It is almost three 
times as common in women as men.6,7
Significant sex specific associations 
between glucocorticoid receptor (GR) 
gene polymorphisms and the HPA axis 
responses to psychosocial stress as well 
as to glucocorticoid (GC) sensitivity have 
been reported.8 In familial glucocorticoid 
resistance, which is inherited as an 
autosomal recessive or dominant disorder 
characterized by glucocorticoid receptor 
gene mutations, decreased cortisol 
effects and secondary ACTH release 
occur. Clinical presentation depends on 
age at presentation, biological sex of 
the subject and organ specific effects. 
Females can present with virilisation 
and menstrual irregularities, both sexes 
with precocious puberty, males with 
disorders of spermatogenesis and fertility 
whilst hypertension and hypokalaemic 
alkalosis occur in both sexes. This provides 
an excellent example of differential 
modulation of endocrine gland activity by 
glucocorticoids and sex steroids.9
Cardiometabolic disease
Diabetes and cardiometabolic disease, 
whilst not generally perceived as 
“endocrine” disorders, are similarly 
associated with significant pancreatic, 
hepatic, skeletal muscle and adipose tissue 
functional aberrations and are no exception 
to the influences of both gender and sex 
on the endocrine system in its broadest 
sense. 
In Type1 Diabetes Mellitus (T1 DM), an 
autoimmune endocrine disorder,  there is 
approximately a 1:1 gender distribution of 
the disease. However, there is a switch in 
the gender specific ratio with adulthood 
in that below 18 yrs of age, the incidence 
of TI DM in women is higher than in 
males but above 18 years of age, there 
is a reversal in this ratio.10 Furthermore, 
the cumulative incidence of certain 
complications of diabetes such as End 
Stage renal Disease (ESRD) varies in an 
age and sex dependent fashion depending 
on the age of onset of the disease. 
For example, in the Finnish Diabetic 
Nephropathy study, the incidence of ESRD 
and diabetic retinopathy doubled in males 
compared to females if the age of onset of 
diabetes was above 15 years of age.11
Diabesity is a condition that has 
reaching epidemic status worldwide with 
biological and psychosocial factors, sex 
and gender widely accepted as playing 
a significant role in the aetiology of 
this condition. Gene expression, body 
fat distribution, adipocytokine activitiy 
and inflammation as well sex hormone 
levels have been shown to be modulated 
by a multitude of environmental factors 
including lifestyle, socioeconomic status, 
level of education, culture, migrations 
and epigenetics. In utero influences on 
fetal development including over- and 
undernutrition, alcohol, stress, smoking, 
and environmental toxins all can affect the 
eventual phenotype of the offspring. For 
instance, male infants born during times of 
starvation are more prone to develop DM. 
The Scottish Care Information Diabetes 
Collaboration revealed that at all ages, 
males are diagnosed with DM at lower 
Body Mass Index (BMI) levels than 
women.12 An analysis of  insulin sensitivity 
and beta cell function in healthy 
subjects with normal glucose tolerance 
revealed that, women have better insulin 
sensitivity and secretion adjusted for 
age and BMI than men. On Oral Glucose 
Tolerance Testing (OGTT), these women 
had lower mean FBGs and higher 2 hourly 
blood glucose levels.13 On further analysis, 
prolonged gut glucose absorption was 
observed in healthy women as compared 
to men which translated into a higher 
prevalence of Impaired Glucose Tolerance 
(IGT) in women14.  This could explain why 
in the prediabetes stage, women are more 
Key points
•	 Clear evidence of sex related differences in disease incidence and prevalence. 
•	 Disease manifestation and progression can be influenced by both sex and gender. 
•	 Limited data are available with respect to gender and sex specific medicine in 
endocrinology.
•	 A holistic approach to disease diagnosis and management must take gender and sex 
specific aspects into consideration.
•	 Further research into this area are essential to facilitate appropriate, equitable and 
holistic health care provision.
likely to have impaired glucose tolerance 
(IGT) and men more often have impaired 
fasting glucose (IFG). 
Age-dependent changes in sex hormone 
levels also lead to changes in metabolism. 
Postmenopausal females  have  lower 
insulin sensitivity, decreased beta cell 
function, worsening lipid profiles, and higher 
blood pressure readings as compared to 
premenopausal women. Such changes are 
less marked in men.15 Whilst studies have 
revealed that lower levels of  testosterone  
in men decrease metabolic risk, in women 
higher testosterone levels are associated with 
a higher prevalence of insulin resistance and 
the metabolic syndrome.16 
Socioeconomic conditions
Modulation by socioeconomic factors has 
also been documented in the literature. 
Educational level attained has been shown 
to affect lifestyle, and the prevalence of 
overweight and obesity in both sexes. In 
females attaining a lower level of education  
the risk of diabetes and hypertension  
increases whereas in men it is the risk of 
stroke that increases.17
Conclusion
In conclusion, analysis of disease 
susceptibility and onset, disease course, 
progression and response to treatment 
reveals a multitude of intrinsic and extrinsic 
modulatory factors which can lead to 
differential effects and outcomes in males 
and females. Response to interventions and 
medications can also exhibit sex and gender 
specific differences and ultimately a holistic 
approach to the management of disease in 
individuals needs to take these differences 
into account. Future research needs to focus 
on further elucidation of the these factors 
and of the mechanisms involved in gender 
specific medicine.
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